Indonesia is using an unusual metric to help determine who is at the front of the queue in its coronavirus vaccine programme: likes and followers on Instagram and YouTube.
The country is prioritising healthcare and public service workers as it embarks on the biggest mass inoculation drive of CoronaVac, the jab developed by Chinese pharmaceutical company Sinovac, outside mainland China.
But it is also prioritising social media influencers in the hope that, as they broadcast their vaccinations to their millions of social media followers, it will help persuade a sceptical public.
您已閱讀17%（582字），剩餘83%（2927字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。